TrialCompass TCL
Back to results
RecruitingPriority 4 · Lower priorityNCT05978141

A Registry for People With T-cell Lymphoma

ClinicalTrials.gov

Plain-language summary

This trial is studying Optional Blood Sample and Nail Sample for people with a type of T-cell lymphoma called AITL. The study measures how well this treatment works and monitors for side effects. It is widely available at 26 US locations.

Who can join (key eligibility)

  • See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Optional Blood Sample and Nail Sample (OTHER): Participants may provide optional research blood and nail samples for biobanking and future use

Drugs / treatments
Optional Blood Sample and Nail Sample
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

A Registry for People With T-cell Lymphoma

NCT05978141

Phase: | Status: Recruiting | Priority: Lower

Plain-language summary

This trial is studying Optional Blood Sample and Nail Sample for people with a type of T-cell lymphoma called AITL. The study measures how well this treatment works and monitors for side effects. It is widely available at 26 US locations.

Who can join

  • See full trial listing for complete eligibility

What's being tested

Optional Blood Sample and Nail Sample (OTHER): Participants may provide optional research blood and nail samples for biobanking and future use

Drugs / treatments: Optional Blood Sample and Nail Sample

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 1000 patients

Primary endpoint: Number of participants populating the T-cell Lymphoma Master Repository/TCLMR

Ages: — to —

Start date: 2023-07-27 | Est. completion: 2030-07-27

Locations

26 US sites · 26 total

California, Colorado, Connecticut, Florida, Georgia, Illinois, Massachusetts, Minnesota, Missouri, Nebraska, New Jersey, New York, Ohio, Pennsylvania, Texas

Contact

Steven Horwitz, MD | horwitzs@MSKCC.ORG | 646-608-2680

Sponsor: Memorial Sloan Kettering Cancer Center (OTHER)

Tags

AITL/TFH · ALCL ALK− · ALCL ALK+ · ATLL · CTCL · EATL · ENKTL · HSTCL · MEITL · PTCL-NOS · SPTCL · any

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT05978141

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.